Chiang Y, Lien C, Su W, Yen T, Chen Y, Lai Y
BMC Palliat Care. 2024; 23(1):150.
PMID: 38877477
PMC: 11177451.
DOI: 10.1186/s12904-024-01483-7.
Tekie Y, Nigatu Y, Mekonnen W, Berhe Y
Front Oncol. 2024; 13:1248921.
PMID: 38264754
PMC: 10805268.
DOI: 10.3389/fonc.2023.1248921.
Phongtankuel V, Czaja S, Park T, Dignam R, Adelman R, Shah S
Contemp Clin Trials. 2023; 136:107389.
PMID: 37972753
PMC: 10922463.
DOI: 10.1016/j.cct.2023.107389.
Mercadante S
J Anesth Analg Crit Care. 2023; 3(1):23.
PMID: 37480136
PMC: 10360268.
DOI: 10.1186/s44158-023-00101-x.
Bossi P, Escobar Y, Pea F
Front Pain Res (Lausanne). 2022; 3:893530.
PMID: 35721659
PMC: 9204512.
DOI: 10.3389/fpain.2022.893530.
The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain.
Mercadante S, Maltoni M, Russo D, Adile C, Ferrera P, Rossi R
Cancers (Basel). 2021; 13(5).
PMID: 33801478
PMC: 7958843.
DOI: 10.3390/cancers13051058.
[Use of rapid-onset fentanyl preparations beyond indication : A random questionnaire survey among congress participants and pain physicians].
Wirz S, Schenk M, Hofbauer H, Wartenberg H, Cascella M, Kieselbach K
Schmerz. 2020; 35(2):114-123.
PMID: 32975670
DOI: 10.1007/s00482-020-00503-8.
Patient Satisfaction with Fentanyl Pectin Nasal Spray in Breakthrough Cancer Pain Management During Radiotherapy for Head and Neck Cancer.
Pointreau Y, Bensadoun R, Bera G, Sire C, Ruffier A, Janoray G
Patient Prefer Adherence. 2020; 14:859-868.
PMID: 32546980
PMC: 7247611.
DOI: 10.2147/PPA.S246757.
Identifying the Prevalence and Correlates of Caregiver-Reported Symptoms in Home Hospice Patients at the End of Life.
Phongtankuel V, Teresi J, Eimicke J, Kong J, Adelman R, Prigerson H
J Palliat Med. 2019; 23(5):635-640.
PMID: 31873053
PMC: 7232637.
DOI: 10.1089/jpm.2019.0324.
Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain.
Mercadante S, Caraceni A, Masedu F, Scipioni T, Aielli F
Oncologist. 2019; 25(2):156-160.
PMID: 31862860
PMC: 7011660.
DOI: 10.1634/theoncologist.2019-0542.
Practical management of opioid rotation and equianalgesia.
Treillet E, Laurent S, Hadjiat Y
J Pain Res. 2018; 11:2587-2601.
PMID: 30464578
PMC: 6211309.
DOI: 10.2147/JPR.S170269.
Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP).
Camps Herrero C, Reina Zoilo J, Monge Martin D, Caballero Martinez F, Guillem Porta V, Aranda Aguilar E
Clin Transl Oncol. 2018; 21(3):380-390.
PMID: 30094793
DOI: 10.1007/s12094-018-1925-1.
Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients.
Mercadante S, Marchetti P, Cuomo A, Caraceni A, Mediati R, Vellucci R
Cancers (Basel). 2018; 10(6).
PMID: 29865170
PMC: 6025469.
DOI: 10.3390/cancers10060175.
Rapid acting fentanyl formulations in breakthrough pain in cancer. Drug selection by means of the System of Objectified Judgement Analysis.
Janknegt R, van den Beuken M, Schiere S, Uberall M, Knaggs R, Hanley J
Eur J Hosp Pharm. 2018; 25(3):e2.
PMID: 29732145
PMC: 5931243.
DOI: 10.1136/ejhpharm-2016-001127.
Characteristics and Treatment of Breakthrought Pain (BTcP) in Palliative Care.
Husic S, Imamovic S, Matic S, Sukalo A
Med Arch. 2017; 71(4):246-250.
PMID: 28974843
PMC: 5585809.
DOI: 10.5455/medarh.2017.71.246-250.
Matrix stimulation in cancer pain: Methodology, safety and effectiveness.
Mucke M, Tils M, Conrad R, Kravchenko D, Cuhls H, Radbruch L
Eur J Pain. 2017; 22(1):58-71.
PMID: 28805336
PMC: 5763394.
DOI: 10.1002/ejp.1089.
Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment.
Cortesi P, DAngiolella L, Vellucci R, Allegri M, Casale G, Favaretti C
PLoS One. 2017; 12(6):e0179523.
PMID: 28654672
PMC: 5487011.
DOI: 10.1371/journal.pone.0179523.
Development and performance of a diagnostic/prognostic scoring system for breakthrough pain.
Samolsky Dekel B, Palma M, Sorella M, Gori A, Vasarri A, Melotti R
J Pain Res. 2017; 10:1327-1335.
PMID: 28615964
PMC: 5459964.
DOI: 10.2147/JPR.S126132.
Association Between Nursing Visits and Hospital-Related Disenrollment in the Home Hospice Population.
Phongtankuel V, Adelman R, Trevino K, Abramson E, Johnson P, Oromendia C
Am J Hosp Palliat Care. 2017; 35(2):316-323.
PMID: 28285542
PMC: 5494025.
DOI: 10.1177/1049909117697933.
Events Leading to Hospital-Related Disenrollment of Home Hospice Patients: A Study of Primary Caregivers' Perspectives.
Phongtankuel V, Paustian S, Reid M, Finley A, Martin A, Delfs J
J Palliat Med. 2016; 20(3):260-265.
PMID: 27893951
PMC: 5333527.
DOI: 10.1089/jpm.2015.0550.